Evolution and Core Processes in Gene Expression

Determine which screening tests are indicated for particular patients, according to USPSTF guidelines. Employ Guideline recommendations presented for common disorders such as HBP, Lipids, STD’s, Cancers-lung, Cx, Breast, etc; AAA, Hep B & C; T2DM, etc, Advise your patients regarding vitamins and supplements as per the USPSTF and Evidence, Order appropriate immunizations for adult patients as per the ACIP and CDC Schedules.

The RARE Health Equity Summit was developed in order to gain a better understanding of persistent gaps in diagnostic challenges for underserved/underrepresented patient communities and align next steps on how to address health inequities of the rare disease community.

Precision & Personalized Medicine has grown from a part of the vision of precision medicine to part of clinical practice in several settings. While it is still evolving and its promise is not fully realized, personalized medicine is making a difference in the lives of cancer patients and those with rare genetic diseases. Early experience in implementing personalized medicine is both exciting and sobering. It is transforming medical care for the better for some but there is a long way to go for many diseases and it magnifies systemic health inequalities.

Cell and Gene therapies are life-changing new categories of medicines whose full potential is only just beginning to emerge. They are cutting-edge and rapidly progressing fields of Biological Therapies. Both therapies aim to treat, prevent or potentially cure diseases and both approaches offer the potential to diminish the fundamental cause of genetic and acquired diseases by substituting the missing protein or cells causing the disease’s symptoms. Cell and gene therapies may offer longer lasting effects than traditional medicines. They are overlapping fields of biomedical research and treatments. However, cell and gene therapies work differently.